We aimed to use deep learning (DL) techniques to accurately differentiate Parkinson's disease (PD) from multiple system atrophy (MSA), which share similar clinical presentations. In this retrospective analysis, 206 patients who underwent PET/MR imaging at the Chinese PLA General Hospital were included, having been clinically diagnosed with either PD or MSA; an additional 38 healthy volunteers served as normal controls (NC). All subjects were randomly assigned to the training and test sets at a ratio of 7:3. The input to the model consists of 10 two-dimensional (2D) slices in axial, coronal, and sagittal planes from multi-modal images. A modified Residual Block Network with 18 layers (ResNet18) was trained with different modal images, to classify PD, MSA, and NC. A four-fold cross-validation method was applied in the training set. Performance evaluations included accuracy, precision, recall, F1 score, Receiver operating characteristic (ROC), and area under the ROC curve (AUC). Six single-modal models and seven multi-modal models were trained and tested. The PET models outperformed MRI models. The ¹¹C-methyl-N-2β-carbomethoxy-3β-(4-fluorophenyl)-tropanel (¹¹C-CFT) -Apparent Diffusion Coefficient (ADC) model showed the best classification, which resulted in 0.97 accuracy, 0.93 precision, 0.95 recall, 0.92 F1, and 0.96 AUC. In the test set, the accuracy, precision, recall, and F1 score of the CFT-ADC model were 0.70, 0.73, 0.93, and 0.82, respectively. The proposed DL method shows potential as a high-performance assisting tool for the accurate diagnosis of PD and MSA. A multi-modal and multi-sequence model could further enhance the ability to classify PD.

The accurate preoperative staging of laryngeal squamous cell carcinoma (LSCC) provides valuable guidance for clinical decision-making. The objective of this study was to establish a multiparametric MRI model using radiomics and deep learning (DL) to preoperatively distinguish between Stages I-II and III-IV of LSCC. Data from 401 histologically confirmed LSCC patients were collected from two centers (training set: 213; internal test set: 91; external test set: 97). Radiomics features were extracted from the MRI images, and seven radiomics models based on single and combined sequences were developed via random forest (RF). A DL model was constructed via ResNet 18, where DL features were extracted from its final fully connected layer. These features were fused with crucial radiomics features to create a combined model. The performance of the models was assessed using the area under the receiver operating characteristic (ROC) curve (AUC) and compared with the radiologist performances. The predictive capability of the combined model for Progression-Free Survival (PFS) was evaluated via Kaplan-Meier survival analysis and the Harrell's Concordance Index (C-index). In the external test set, the combined model had an AUC of 0.877 (95% CI 0.807-0.946), outperforming the DL model (AUC: 0.811) and the optimal radiomics model (AUC: 0.835). The combined model significantly outperformed both the DL (p = 0.017) and the optimal radiomics models (p = 0.039), and the radiologists (both p < 0.050). Moreover, the combined model demonstrated great prognostic predictive value in patients with LSCC, achieving a C-index of 0.624 for PFS. This combined model enhances preoperative LSCC staging, aiding in making more informed clinical decisions.

The low proton density and high signal decay rate of pulmonary tissue have previously hampered the application of magnetic resonance imaging (MRI) in the clinical evaluation of lung disorders. With the continuing technical advances in scanners, coils, pulse sequences, and image postprocessing, pulmonary MRI can provide structural and functional information with faster imaging speed and improved image quality, which has shown potential to be an alternative and complementary diagnostic method to chest computed tomography (CT). Compared with CT, MRI does not involve ionizing radiation, making it particularly suitable for pediatric patients, pregnant women, and individuals requiring longitudinal monitoring. This narrative review focuses on recent advances in techniques and clinical applications for pulmonary MRI in lung diseases, including lung parenchymal and pulmonary vascular diseases. Future developments, including artificial intelligence-driven technological optimization and assisted diagnosis, hardware advancements, and clinical biomarkers validation, hold the potential to further enhance the clinical utility of pulmonary MRI. EVIDENCE LEVEL: 5 TECHNICAL EFFICACY: Stage 2.

Artificial intelligence (AI) is a revolutionary tool yet to be fully integrated into several health care sectors, including medical imaging. AI can transform how medical imaging is conducted and interpreted, especially in cardio-oncology. This study aims to systematically review the available literature on the use of AI in cardio-oncology imaging to predict cardiotoxicity and describe the possible improvement of different imaging modalities that can be achieved if AI is successfully deployed to routine practice. We conducted a database search in PubMed, Ovid MEDLINE, Cochrane Library, CINAHL, and Google Scholar from inception to 2023 using the AI research assistant tool (Elicit) to search for original studies reporting AI outcomes in adult patients diagnosed with any cancer and undergoing cardiotoxicity assessment. Outcomes included incidence of cardiotoxicity, left ventricular ejection fraction, risk factors associated with cardiotoxicity, heart failure, myocardial dysfunction, signs of cancer therapy-related cardiovascular toxicity, echocardiography, and cardiac magnetic resonance imaging. Descriptive information about each study was recorded, including imaging technique, AI model, outcomes, and limitations. The systematic search resulted in 7 studies conducted between 2018 and 2023, which are included in this review. Most of these studies were conducted in the United States (71%), included patients with breast cancer (86%), and used magnetic resonance imaging as the imaging modality (57%). The quality assessment of the studies had an average of 86% compliance in all of the tool's sections. In conclusion, this systematic review demonstrates the potential of AI to enhance cardio-oncology imaging for predicting cardiotoxicity in patients with cancer. Our findings suggest that AI can enhance the accuracy and efficiency of cardiotoxicity assessments. However, further research through larger, multicenter trials is needed to validate these applications and refine AI technologies for routine use, paving the way for improved patient outcomes in cancer survivors at risk of cardiotoxicity.

This study aimed to investigate the performance of an artificial intelligence (AI)-based lung nodule detection program in ultra-low-dose CT (ULDCT) imaging, with a focus on the influence of various image reconstruction methods on detection accuracy. A chest phantom embedded with artificial lung nodules (solid and ground-glass nodules [GGNs]; diameters: 12 mm, 8 mm, 5 mm, and 3 mm) was scanned using six combinations of tube currents (160 mA, 80 mA, and 10 mA) and voltages (120 kV and 80 kV) on a Canon Aquilion One CT scanner. Images were reconstructed using filtered back projection (FBP), hybrid iterative reconstruction (HIR), model-based iterative reconstruction (MBIR), and deep learning reconstruction (DLR). Nodule detection was performed using an AI-based lung nodule detection program, and performance metrics were analyzed across different reconstruction methods and radiation dose protocols. At the lowest dose protocol (80 kV, 10 mA), FBP showed a 0% detection rate for all nodule sizes. HIR and DLR consistently achieved 100% detection rates for solid nodules ≥ 5 mm and GGNs ≥ 8 mm. No method detected 3 mm GGNs under any protocol. DLR demonstrated the highest detection rates, even under ultra-low-dose settings, while maintaining high image quality. AI-based lung nodule detection in ULDCT is strongly dependent on the choice of image reconstruction method.

Shortcut learning has been identified as a source of algorithmic unfairness in medical imaging artificial intelligence (AI), but its impact on photoacoustic tomography (PAT), particularly concerning sex bias, remains underexplored. This study investigates this issue using peripheral artery disease (PAD) diagnosis as a specific clinical application. To examine the potential for sex bias due to shortcut learning in convolutional neural network (CNNs) and assess how such biases might affect diagnostic predictions, we created training and test datasets with varying PAD prevalence between sexes. Using these datasets, we explored (1) whether CNNs can classify the sex from imaging data, (2) how sex-specific prevalence shifts impact PAD diagnosis performance and underdiagnosis disparity between sexes, and (3) how similarly CNNs encode sex and PAD features. Our study with 147 individuals demonstrates that CNNs can classify the sex from calf muscle PAT images, achieving an AUROC of 0.75. For PAD diagnosis, models trained on data with imbalanced sex-specific disease prevalence experienced significant performance drops (up to 0.21 AUROC) when applied to balanced test sets. Additionally, greater imbalances in sex-specific prevalence within the training data exacerbated underdiagnosis disparities between sexes. Finally, we identify evidence of shortcut learning by demonstrating the effective reuse of learned feature representations between PAD diagnosis and sex classification tasks. CNN-based models trained on PAT data may engage in shortcut learning by leveraging sex-related features, leading to biased and unreliable diagnostic predictions. Addressing demographic-specific prevalence imbalances and preventing shortcut learning is critical for developing models in the medical field that are both accurate and equitable across diverse patient populations.

Artificial intelligence (AI) promises to compress stroke treatment timelines, yet its clinical return on investment remains uncertain. We interrogate state‑of‑the‑art AI platforms across imaging, workflow orchestration, and outcome prediction to clarify value drivers and execution risks. Convolutional, recurrent, and transformer architectures now trigger large‑vessel‑occlusion alerts, delineate ischemic core in seconds, and forecast 90‑day function. Commercial deployments-RapidAI, Viz.ai, Aidoc-report double‑digit reductions in door‑to‑needle metrics and expanded thrombectomy eligibility. However, dataset bias, opaque reasoning, and limited external validation constrain scalability. Hybrid image‑plus‑clinical models elevate predictive accuracy but intensify data‑governance demands. AI can operationalize precision stroke care, but enterprise‑grade adoption requires federated data pipelines, explainable‑AI dashboards, and fit‑for‑purpose regulation. Prospective multicenter trials and continuous lifecycle surveillance are mandatory to convert algorithmic promise into reproducible, equitable patient benefit.

This study introduces APD-FFNet, a novel, explainable deep learning architecture for automated periodontitis diagnosis using panoramic radiographs. A total of 337 panoramic radiographs, annotated by a periodontist, served as the dataset. APD-FFNet combines custom convolutional and transformer-based layers within a deep feature fusion framework that captures both local and global contextual features. Performance was evaluated using accuracy, the F1 score, the area under the receiver operating characteristic curve, the Jaccard similarity coefficient, and the Matthews correlation coefficient. McNemar's test confirmed statistical significance, and SHapley Additive exPlanations provided interpretability insights. APD-FFNet achieved 94% accuracy, a 93.88% F1 score, 93.47% area under the receiver operating characteristic curve, 88.47% Jaccard similarity coefficient, and 88.46% Matthews correlation coefficient, surpassing comparable approaches. McNemar's test validated these findings (p < 0.05). Explanations generated by SHapley Additive exPlanations highlighted important regions in each radiograph, supporting clinical applicability. By merging convolutional and transformer-based layers, APD-FFNet establishes a new benchmark in automated, interpretable periodontitis diagnosis, with low hyperparameter sensitivity facilitating its integration into regular dental practice. Its adaptable design suggests broader relevance to other medical imaging domains. This is the first feature fusion method specifically devised for periodontitis diagnosis, supported by an expert-curated dataset and advanced explainable artificial intelligence. Its robust accuracy, low hyperparameter sensitivity, and transparent outputs set a new standard for automated periodontal analysis.

Lung cancer is the leading cause of cancer-related mortality worldwide. Early lung cancer detection improves lung cancer-related mortality and survival. This report summarizes presentations and panel discussions from a webinar, "The Present and Future of Lung Cancer Screening: Latest Evidence and AI Perspectives." The webinar provided the perspectives of experts from the United States, United Kingdom, and China on evidence-based recommendations and management in lung cancer screening (LCS), barriers, and the role of artificial intelligence (AI). With several countries now incorporating the utilization of AI in their screening programs, AI offers potential solutions to some of the challenges associated with LCS.